Thomas Newman
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 194 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $1,667 and has fallen 96.6% since, to $57 in 2021.
Across 194 payments — averaging $16.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$469
- Novartis$305
- Sanofi$222
- Biogen$152
- Supernus Pharmaceuticals, Inc.$137
- Amgen$133
- plus $2K from 29 others
What the payments were for
- Speaking & faculty fees$1043%
- Food & beverage$3,02097%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 34 | $469 |
| Novartis | 24 | $305 |
| Sanofi | 12 | $222 |
| Biogen | 8 | $152 |
| Supernus Pharmaceuticals, Inc. | 15 | $137 |
| Amgen | 7 | $133 |
| Upsher-smith Laboratories LLC | 6 | $126 |
| Adamas Pharmaceuticals, Inc. | 6 | $117 |
| Sunovion Pharmaceuticals Inc. | 7 | $111 |
| UCB, Inc. | 5 | $106 |
| Acorda Therapeutics, Inc | 5 | $104 |
| AstraZeneca | 4 | $100 |
| E.r. Squibb & Sons, L.L.C. | 5 | $99 |
| Vanda Pharmaceuticals Inc. | 5 | $99 |
| Teva Pharmaceuticals USA, Inc. | 6 | $90 |
| Arbor Pharmaceuticals, Inc. | 5 | $79 |
| Tanabe Pharma America, Inc. | 5 | $71 |
| Amneal Pharmaceuticals LLC | 4 | $65 |
| Genentech USA, Inc. | 3 | $59 |
| EMD Serono, Inc. | 3 | $51 |
| MDD US Operations, LLC | 3 | $50 |
| Avanir Pharmaceuticals, Inc. | 3 | $47 |
| Acadia Pharmaceuticals Inc | 2 | $38 |
| Tersera Therapeutics LLC | 2 | $36 |
| Lilly USA, LLC | 2 | $34 |
| Lundbeck LLC | 2 | $34 |
| Neos Therapeutics, LP | 2 | $34 |
| Zyla Life Sciences, Inc. | 2 | $29 |
| Bausch Health US, LLC | 1 | $23 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| Adlon Therapeutics L.p. | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Pfizer | 1 | $15 |
| Assertio Therapeutics, Inc. | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $13 |
How this compares
$3,123 in reported general payments places this provider in the 55th percentile of 1,434 neurology providers in Florida.
Other neurology in Tampa
- Selim BenbadisTampa$2.1M
- Derrick RobertsonTampa$1.8M
- Robert HauserTampa$1.6M
- David RoseTampa$1.4M
- Mark CascioneTampa$1.2M
- Tuan VuTampa$1M
- Katherine StandleyTampa$735K
- Susan SteenTampa$341K
- Rossitza ChichkovaTampa$294K
- Brody HenkelTampa$262K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.